anti-EGP-2 immunotoxin MOC31-PE
Term · Oncology and biomedicine · MLC-T-ONC-010624
An immunotoxin consisting of a monoclonal antibody directed against epithelial glycoprotein-2 (EP-2, or epithelial cell adhesion molecule (EpCAM)) conjugated to the bacterial toxin Pseudomonas exotoxin A (PE) with potential antineoplastic activity. Upon administration of anti-EGP-2 immunotoxin MOC31-PE, the monoclonal antibody moiety targets and binds to EP-2. Upon internalization, the Pseudomonas exotoxin A moiety then inactivates elongation factor 2 (EF-2) through ADP ribosylation, resulting in inhibition of protein synthesis in EP-2-expressing cells. EP-2, a tumor-associated antigen, is overexpressed in a variety of cancer cell types.
| Identifier | MLC-T-ONC-010624 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | anti-epithelial glycoprotein-2 immunotoxin MOC31-PE |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-010624",
"term": "anti-EGP-2 immunotoxin MOC31-PE",
"field": "Oncology and biomedicine",
"definition": "An immunotoxin consisting of a monoclonal antibody directed against epithelial glycoprotein-2 (EP-2, or epithelial cell adhesion molecule (EpCAM)) conjugated to the bacterial toxin Pseudomonas exotoxin A (PE) with potential antineoplastic activity. Upon administration of anti-EGP-2 immunotoxin MOC31-PE, the monoclonal antibody moiety targets and binds to EP-2. Upon internalization, the Pseudomonas exotoxin A moiety then inactivates elongation factor 2 (EF-2) through ADP ribosylation, resulting in inhibition of protein synthesis in EP-2-expressing cells. EP-2, a tumor-associated antigen, is overexpressed in a variety of cancer cell types.",
"synonyms": [
"anti-epithelial glycoprotein-2 immunotoxin MOC31-PE"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/anti-egp-2-immunotoxin-moc31-pe/"
}
Record 1,720 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.